HB1296 (2024) Detail

Relative to insurance coverage for diagnostic and supplemental breast examinations.


CHAPTER 32

HB 1296-FN - FINAL VERSION

 

28Mar2024... 1133h

2024 SESSION

24-2186

05/10

 

HOUSE BILL 1296

 

AN ACT relative to insurance coverage for diagnostic and supplemental breast examinations.

 

SPONSORS: Rep. Rombeau, Hills. 2; Rep. W. Thomas, Hills. 12; Rep. Ming, Hills. 35; Rep. Simpson, Rock. 33; Rep. Bay, Straf. 21; Rep. L. Foxx, Hills. 2; Rep. McGhee, Hills. 35; Rep. Coker, Belk. 2; Rep. Bogert, Belk. 5; Sen. Perkins Kwoka, Dist 21; Sen. Soucy, Dist 18; Sen. Prentiss, Dist 5; Sen. Whitley, Dist 15

 

COMMITTEE: Commerce and Consumer Affairs

 

─────────────────────────────────────────────────────────────────

 

ANALYSIS

 

This bill provides that certain insurers that provide diagnostic and supplemental breast examinations shall not impose co-payments, deductibles, or other cost-sharing requirements.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

28Mar2024... 1133h 24-2186

05/10

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Four

 

AN ACT relative to insurance coverage for diagnostic and supplemental breast examinations.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

32:1  New Section; Women's Health Care; Coverage for Diagnostic and Supplemental Breast Examinations.  Amend RSA 417-D by inserting after section 2-b the following new section:

417-D:2-c  Coverage for Diagnostic and Supplemental Breast Examinations.

I.  No group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to screening and diagnostic and supplemental breast examinations furnished to an individual enrolled under such plan or coverage, shall impose any cost-sharing requirements for such services.

II.  For a health care contract that meets the definition of a "high deductible plan" set forth in 26 U.S.C. section 223(c)(2), this requirement shall apply only after the enrollee has satisfied the minimum deductible under section 223 for the year, except with respect to items or services that are preventive care pursuant to section 223(c)(2)(C) of the federal Internal Revenue Code, in which case paragraph I shall apply regardless of whether the minimum deductible under section 223 has been satisfied.

III.  In this section:

(a)  "Cost-sharing requirements" mean a deductible, coinsurance, copayment, and any maximum limitation on the application of such a deductible, coinsurance, copayment or similar out-of-pocket expense.

(b)  "Diagnostic breast examination" means a medically necessary and appropriate examination of the breast, including such an examination using diagnostic mammography, breast magnetic resonance imaging, or breast ultrasound, that is:

(1)  Used to evaluate an abnormality seen or suspected from a screening examination for breast cancer; or

(2)  Used to evaluate an abnormality detected by another means of examination.

(c)  "Supplemental breast examination" means a medically necessary and appropriate examination of the breast, including such an examination using breast magnetic resonance imaging, or breast ultrasound, that is:

(1)  Used to screen for breast cancer when there is no abnormality seen or suspected; and

(2)  Based on personal or family medical history, or additional factors that may increase the individual’s risk of breast cancer.

32:2  Effective Date.  This act shall take effect January 1, 2025.

 

Approved: May 31, 2024

Effective Date: January 01, 2025

 

 

 

Amendments

Date Amendment
March 20, 2024 2024-1133h

Links


Date Body Type
Jan. 18, 2024 House Hearing
March 13, 2024 House Exec Session
March 20, 2024 House Exec Session
March 20, 2024 House Floor Vote
April 10, 2024 Senate Hearing
April 18, 2024 Senate Floor Vote

Bill Text Revisions

HB1296 Revision: 42600 Date: June 3, 2024, 1:19 p.m.
HB1296 Revision: 41674 Date: April 18, 2024, 10:59 a.m.
HB1296 Revision: 41450 Date: March 28, 2024, 2:23 p.m.
HB1296 Revision: 41327 Date: March 20, 2024, 5:12 p.m.
HB1296 Revision: 39804 Date: March 15, 2024, 2:50 p.m.
HB1296 Revision: 44172 Date: Nov. 6, 2023, 10:36 a.m.
HB1296 Revision: 44173 Date: Oct. 3, 2023, 3:01 p.m.

Docket


June 4, 2024: Signed by Governor Sununu 05/31/2024; Chapter 32; eff: 01/01/2025 HJ 15


May 23, 2024: Enrolled (in recess of) 05/23/2024 HJ 14 P. 176


May 23, 2024: Enrolled Adopted, VV, (In recess 05/22/2024); SJ 15


April 18, 2024: Ought to Pass: MA, VV; OT3rdg; 04/18/2024; SJ 10


April 10, 2024: Committee Report: Ought to Pass, 04/18/2024, Vote 5-0; SC 15


April 4, 2024: Hearing: 04/10/2024, Room 101, LOB, 09:15 am; SC 14


April 2, 2024: Introduced 03/21/2024 and Referred to Health and Human Services; SJ 8


March 28, 2024: Ought to Pass with Amendment 2024-1133h: MA VV 03/28/2024 HJ 10 P. 11


March 28, 2024: Amendment # 2024-1133h: AA VV 03/28/2024 HJ 10 P. 11


March 20, 2024: Committee Report: Ought to Pass with Amendment # 2024-1133h 03/20/2024 (Vote 17-0; CC) HC 12 P. 7


March 13, 2024: Executive Session: 03/20/2024 10:00 am LOB 302-304


March 7, 2024: Executive Session: 03/13/2024 10:00 am LOB 302-304


Feb. 14, 2024: Subcommittee Work Session: 02/20/2024 10:00 am LOB 305


Feb. 7, 2024: Subcommittee Work Session: 02/14/2024 10:00 am LOB 302-304


Jan. 9, 2024: Public Hearing: 01/18/2024 01:45 pm LOB 302-304


Dec. 6, 2023: Introduced 01/03/2024 and referred to Commerce and Consumer Affairs HJ 1 P. 15